Novel lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model

Emrah Yatkin, Lauri Polari, Teemu D. Laajala, Annika Smeds, Christer Eckerman, Bjarne Holmbom, Niina M. Saarinen, Tero Aittokallio, Sari I. Mäkelä

    Research output: Contribution to journalArticleScientificpeer-review

    20 Citations (Scopus)
    Original languageUndefined/Unknown
    Pages (from-to)
    JournalPLoS ONE
    Volume9
    Issue number4
    DOIs
    Publication statusPublished - 2014
    MoE publication typeA1 Journal article-refereed

    Keywords

    • Lignans
    • prostate cancer

    Cite this